- What is the Athlete Mindset?
- Parallels between elite sport and clinical trial delivery
- Applying the athlete-style discipline, goal-setting, ‘pivot quickly’ mindset and performance tracking in delivering complex oncology trials
- Translating setbacks into learnings and future strengths- The drive for continuous improvement-The perfect race!
- Sustaining performance and energy across multi-year clinical trials- The Long-Distance Athlete
Archives: Agenda
KEYNOTE PANEL UK Clinical Trials at a Crossroads: Pricing, Investment and Performance Challenges
- How pricing frameworks like VPAG are influencing pharma exit decisions
- Consequences of major R&D pullbacks for the UK research ecosystem
- Persistent issues: slow approvals, fragmented delivery and rising costs
- What policy and industry shifts are needed to reverse the trend
KEYNOTE: A New Chapter for UK Clinical Trials: Regulation Reform and the Rise of AI
- The impact of the new UK clinical trial regulations coming into force in April 2026 and what they mean for sponsors, investigators, and trial delivery
- Government priorities and progress across the UK clinical research ecosystem two years on
- How artificial intelligence is transforming clinical trial design, feasibility, patient identification, and operational efficiency
- Cross-sector collaboration between regulators, industry, and the NHS to strengthen the UK’s position as a leading destination for clinical research
- Looking ahead: building a more agile, technology-enabled clinical trials environment in the UK
Registration and Refreshments
PANEL DISCUSSION Harnessing Real-World Data and Registries in Clinical Trials: UK & Ireland Perspectives
- Overview of available RWD sources and disease registries across the UK and Ireland, and how they can support trial design.
- Leveraging RWD to inform patient eligibility, site selection, and endpoint development.
- Practical considerations for integrating registry data with trial datasets while ensuring data quality and regulatory compliance.
- Case studies demonstrating how RWD and registries have accelerated clinical trial insights and improved patient outcomes.
PANEL DISCUSSION From Transactional Outsourcing to Strategic Partnership: Aligning Incentives, Expectations, and Execution in Clinical Trials
- Planning for successful sponsor–vendor relationships
- Common challenges and pitfalls with vendors and how to address them
- Improving transparency and alignment across multi-partner trial ecosystems
- What effective strategic partnership looks like in practice
SPOTLIGHT – Innovation in Rare Disease
|
Afternoon refreshments, networking & Apple prize draw
FIRESIDE CHAT Risks & Controversies of AI in Clinical Trials
- Automation bias in practice: Real-world cases show dosing errors occurring when clinicians rely on AI outputs without independent verification.
- Human oversight failures: Over-reliance on AI, combined with missed pharmacist checks, can directly compromise patient safety.
- Cognitive deskilling risk: Persistent dependence on AI may erode critical thinking, clinical judgement, and professional expertise over time.
- Long-term human impact: Growing concern that excessive cognitive offloading to AI could contribute to reduced mental resilience and potential long-term cognitive health risks, highlighting the need for balanced human – AI interaction.
From Friction to Flow: The Future of Imaging in Clinical Trials
- Automation from scan to endpoint
- Imaging biomarkers and expert readers
- Site connectivity for full traceability